SSRIs and SNRIs are the best-studied and most widely recommended medications for long-term anxiety treatment. No single drug works best for everyone, but these two classes have the strongest evidence for safety and effectiveness over months and years of continuous use. About 41% of people with generalized anxiety disorder achieve full remission lasting at least a year, and medication choice, timing, and patience all play a role in that outcome.
SSRIs and SNRIs: The First-Line Options
SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors) are the standard starting point for every major anxiety disorder. For generalized anxiety disorder, the FDA has approved escitalopram and paroxetine among SSRIs and venlafaxine and duloxetine among SNRIs. For panic disorder, the approved SSRIs are fluoxetine, sertraline, and paroxetine, with venlafaxine as the SNRI option. For social anxiety disorder, the list includes sertraline, paroxetine, and venlafaxine. Clinical trial data also supports sertraline and fluoxetine for generalized anxiety even beyond their formal approvals.
These medications work by increasing the availability of serotonin (and in the case of SNRIs, norepinephrine) in the brain. But the chemistry shift happens within hours of taking a pill, while symptom relief takes weeks. That delay exists because the real therapeutic changes are slower, downstream adaptations. With SSRIs specifically, the brain gradually dials down certain serotonin receptors that normally act as brakes on serotonin release. Once those receptors become less sensitive, serotonin flows more freely and consistently. This process takes time, which is why you typically need four to eight weeks before noticing meaningful improvement.
The fact that these medications reshape how your brain regulates its own chemistry, rather than just flooding it with a single neurotransmitter, is part of what makes them suitable for long-term use. They don’t produce a high, they don’t require escalating doses to keep working, and their benefits tend to build with sustained use.
Why Benzodiazepines Aren’t Ideal Long Term
Benzodiazepines like alprazolam, lorazepam, and clonazepam work fast, often within minutes. That rapid onset makes them effective for acute anxiety or panic attacks, but it’s also what makes them risky over time. Your brain adapts to their presence, which can lead to tolerance (needing higher doses for the same effect) and physical dependence. Long-term benzodiazepine use has also been linked to cognitive impairment, over-sedation, poor coordination, and an increased risk of developing dementia.
For these reasons, guidelines recommend against prescribing benzodiazepines indefinitely. They’re particularly risky for anyone with a current or past history of substance use. Some prescribers use them as a short bridge during the weeks it takes an SSRI or SNRI to reach full effect, but the long-term anxiety management plan should rely on something else.
Buspirone: A Quieter Alternative
Buspirone is a non-addictive option that works differently from both SSRIs and benzodiazepines. It’s approved specifically for generalized anxiety disorder and has solid long-term data behind it. A 12-month study of 700 patients found that buspirone produced significant, sustained reductions in anxiety, and that the degree of improvement actually increased the longer people took it. After three months, very few patients stopped treatment due to side effects or lack of benefit.
Buspirone doesn’t cause sedation, doesn’t carry addiction risk, and doesn’t produce withdrawal symptoms the way benzodiazepines do. The tradeoff is that it’s slower to work and generally less potent than SSRIs for moderate to severe anxiety. It’s sometimes used on its own for milder cases or added alongside an SSRI to boost the effect.
Side Effects You Should Expect
SSRIs and SNRIs are generally well tolerated, but “well tolerated” in clinical terms doesn’t mean side-effect-free. The early weeks often bring nausea, dizziness, headaches, jitteriness, sleep changes, and stomach issues. These typically fade as your body adjusts.
The longer-term side effects are the ones that matter most for a medication you might take for years. Sexual dysfunction is the most underreported: only 2% to 7% of patients mention it on their own, but when directly asked through questionnaires, the rate jumps to around 55% for SSRIs. This can include reduced desire, difficulty with arousal, or trouble reaching orgasm. It’s a significant quality-of-life issue that’s worth discussing openly with your prescriber, because switching medications or adjusting the dose can sometimes help.
Weight gain is the other common long-term concern. Uncontrolled studies have reported average gains of about 15 pounds with sertraline, 21 pounds with fluoxetine, and 24 pounds with paroxetine over 6 to 12 months of use. These are averages, so individual experiences vary widely. Some people gain nothing, others gain more. Paroxetine tends to be the worst offender in this category, which is one reason prescribers often start with sertraline or escitalopram instead.
How Prescribers Choose Between Them
There’s no definitive ranking of which SSRI or SNRI is “best.” The medications within each class have similar overall effectiveness, so the choice usually comes down to side effect profiles, your other health conditions, and what you’ve tried before. Sertraline and escitalopram are common starting points because they tend to have fewer drug interactions and a relatively mild side effect profile. Venlafaxine and duloxetine (SNRIs) might be preferred if you also have chronic pain, since norepinephrine plays a role in pain signaling.
If the first medication doesn’t work after a proper trial of six to eight weeks at an adequate dose, that doesn’t mean medication won’t work for you. It often takes trying two or three options to find the right fit. About half of people with generalized anxiety disorder meet criteria for diagnostic remission within a year, and a meaningful portion of those who don’t fully remit still experience significant symptom reduction.
What Happens When You Want to Stop
All antidepressant-class medications can cause withdrawal symptoms if stopped abruptly. This is sometimes called discontinuation syndrome, and it can include dizziness, irritability, nausea, brain zaps (brief electric-shock sensations), and a rebound of anxiety symptoms. Paroxetine and venlafaxine tend to produce the most noticeable withdrawal effects because they leave the body quickly.
The key to stopping safely is a slow, gradual taper. Research suggests that tapers should happen over months, not weeks, and should reduce doses in smaller and smaller increments as you approach zero. Cutting a dose in half might seem logical, but the relationship between dose and brain effect isn’t linear. Going from 20 mg to 10 mg is a much smaller change in brain receptor activity than going from 10 mg to zero. Effective tapering programs account for this by using exponential reductions, ending at doses well below the standard therapeutic minimum before stopping entirely.
If you’ve been on medication for a year or more, planning a taper with your prescriber is essential. Rushing the process is the most common cause of difficult withdrawal experiences, and it can be mistaken for a relapse of the original anxiety disorder.
Medication Works Best Alongside Therapy
Long-term medication manages the biological component of anxiety, but it doesn’t teach you new ways to respond to anxious thoughts or situations. Cognitive behavioral therapy (CBT) has strong evidence for anxiety disorders on its own and even stronger evidence when combined with medication. The combination tends to produce better outcomes than either approach alone, and the skills learned in therapy can protect against relapse if you eventually taper off medication. For many people, the most effective long-term plan isn’t choosing between pills and therapy. It’s using both strategically.